Correlation Between GlucoTrack and ReShape Lifesciences

Can any of the company-specific risk be diversified away by investing in both GlucoTrack and ReShape Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlucoTrack and ReShape Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GlucoTrack and ReShape Lifesciences, you can compare the effects of market volatilities on GlucoTrack and ReShape Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlucoTrack with a short position of ReShape Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlucoTrack and ReShape Lifesciences.

Diversification Opportunities for GlucoTrack and ReShape Lifesciences

0.74

Correlation Coefficient

GlucoTrack  ReShape Lifesciences

Poor diversification

The 3 months correlation between GlucoTrack and ReShape is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding GlucoTrack and ReShape Lifesciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ReShape Lifesciences and GlucoTrack is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlucoTrack are associated (or correlated) with ReShape Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ReShape Lifesciences has no effect on the direction of GlucoTrack i.e., GlucoTrack and ReShape Lifesciences go up and down completely randomly.

Pair Corralation between GlucoTrack and ReShape Lifesciences

Given the investment horizon of 90 days GlucoTrack is expected to under-perform the ReShape Lifesciences. In addition to that, GlucoTrack is 1.33 times more volatile than ReShape Lifesciences. It trades about -0.33 of its total potential returns per unit of risk. ReShape Lifesciences is currently generating about -0.32 per unit of volatility. If you would invest  452.00  in ReShape Lifesciences on December 30, 2024 and sell it today you would lose (413.00) from holding ReShape Lifesciences or give up 91.37% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.41%
Values	Daily Returns

GlucoTrack  vs.  ReShape Lifesciences

GlucoTrack

Risk-Adjusted Performance

Very Weak

Over the last 90 days GlucoTrack has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in April 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

ReShape Lifesciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days ReShape Lifesciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's essential indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with GlucoTrack and ReShape Lifesciences

The main advantage of trading using opposite GlucoTrack and ReShape Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlucoTrack position performs unexpectedly, ReShape Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ReShape Lifesciences will offset losses from the drop in ReShape Lifesciences' long position.

The idea behind GlucoTrack and ReShape Lifesciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.